Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity

Wanjun Ma1,2, Shanshan Wei1,2, Bikui Zhang1,2

  • 1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.

Insights

Drug-induced cardiotoxicity can cause severe heart problems. This review details cardiomyocyte death mechanisms and proteins, offering targets for preventing and treating drug-induced heart damage.

Area of Science:

  • Cardiology
  • Toxicology
  • Molecular Biology

Background:

  • Homeostatic regulation of cardiomyocytes is vital for cardiac function.
  • Drug-induced cardiotoxicity leads to serious cardiac diseases like arrhythmia and myocardial infarction.
  • Certain clinical drugs, including anti-cancer and anti-diabetic agents, can cause cardiotoxicity.

Purpose of the Study:

  • To review cardiomyocyte death forms and mechanisms in drug-induced cardiotoxicity.
  • To identify key proteins involved in cardiomyocyte death signaling pathways.
  • To provide a theoretical basis for preventing and treating drug-induced cardiotoxicity.

Main Methods:

  • Literature review of studies on drug-induced cardiotoxicity.
  • Analysis of cardiomyocyte death pathways: apoptosis, autophagy, necrosis, necroptosis, pyroptosis, and ferroptosis.
  • Evaluation of key proteins in cardiomyocyte death signaling.

Main Results:

  • Drug-induced cardiotoxicity manifests through diverse cardiomyocyte death mechanisms.
  • Specific proteins are critical in mediating these death pathways.
  • Understanding these mechanisms and proteins is essential for clinical management.

Conclusions:

  • Drug-induced cardiotoxicity is a significant clinical challenge.
  • Targeting cardiomyocyte death pathways and proteins offers potential therapeutic strategies.
  • This review provides a foundation for developing interventions against drug-induced heart damage.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
256
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
317
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.0K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
381